Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.91 -1.56 (-5.12%)
Official Closing Price Updated: 7:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Is NYSE:PFE a Good Fit for Dividend Investing?
Why PFIZER INC (NYSE:PFE) is a Top Pick for Dividend Investors. 
Via Chartmill
3 Beaten-Down, High-Yield Dividend Stocks That Wall Street Predicts Could Soar More Than 25% Over the Next 12 Months
Analysts view these dividend stocks as great rebound candidates. 
Via The Motley Fool
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic. 
Via Talk Markets
Exposures COVID-19
Pfizer Analysts Cut Their Forecasts Following Q3 Results
Pfizer Inc (NYSE: PFE) reported a loss for the third quarter on Tuesday. 
Via Benzinga
Looking At Pfizer's Recent Unusual Options Activity
Via Benzinga
7 Dividend Stocks That Are a Recipe for Disaster
With these seven dividend stocks to sell, high yields are outweighed by high uncertainty and downside risk. 
Via InvestorPlace
How To Earn $500 A Month From Pfizer Stock After Q3 Results
Pfizer Inc (NYSE: PFE) reported a loss for the third quarter on Tuesday. 
Via Benzinga
Pfizer Skids As Covid Products Drive 41% Sales Decline, Losses
The company reported wider-than-expected losses and light third-quarter sales. 
Via Investor's Business Daily
Exposures COVID-19
Pfizer Earnings Preview
Via Benzinga
GSK Hikes Guidance On The Back Of Its Strong RSV Vaccine Launch
The company is rivaling Pfizer, which also gained approval this year for an RSV vaccine. 
Via Investor's Business Daily
Pfizer Posted a Steep Loss. Is It Time to Sell?
A $5.6 billion inventory write-down isn't what investors wanted to see, but this company is made of many moving pieces. 
Via The Motley Fool
Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On
Are you looking to invest in disrupting stocks like Cathie Woods? Here are three stocks Cathie Wood is betting millions on. 
Via InvestorPlace
3 Top Dividend Stocks to Buy for Long-Term Growth
These long-term dividend stocks to buy represent companies with high cash flow potential for dividend growth. 
Via InvestorPlace
Pfizer (PFE) Q3 2023 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Dressed Up For Data: Halloween Dawns With Head Spinning Amounts Of Numbers, Stocks On Pace For Monthly Loss
(Tuesday market open) A scary October for stocks skids to the finish line today with major U.S. indexes on pace to post  their third straight monthly loss for the first time since early 2020 despite... 
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Pfizer's Coming for AbbVie's Market Share. Here's What It Means for Investors
AbbVie has a head start, but that might not be enough to save its top line. 
Via The Motley Fool
Today's Pharma Tales Of Loss And Success: Pfizer Swings To A Quarterly Loss And Mainz Biomed Reports Positive Interim Screening Campaign Results
As it struggles to navigate the rapid decline of its Covid-19 fame, Pfizer Inc (NYSE: PFE) reported a quarterly loss for the third quarter. 
Via Benzinga
Exposures COVID-19
US Stocks Fall; Pfizer Swings To Q3 Loss
U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Tuesday, the Dow traded down 0.25% to 32,845.12 while the NASDAQ fell 0.50% to 12,726.17.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Pfizer Q3 Earnings: Drugmaker Swings To Quarterly Loss On COVID-19 Write-Offs, Sales Fall 42%
Pfizer Inc (NYSE: PFE) has reported a Q3 adjusted EPS loss of $(0.17) versus a consensus loss of $(0.32), down from EPS inc 
Via Benzinga
Exposures COVID-19
U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive
US stocks are priming for a modestly higher open on Tuesday as traders look to another slew of earnings and the Fed decision. 
Via Benzinga
Topics Economy
Exposures Interest Rates
3 No-Brainer Stocks to Buy With $50 Right Now
These stocks have declined in the double digits over the past few months. 
Via The Motley Fool
Investor Fear Eases Ahead Of Fed's Decision; Dow Notches Best Day Since June
The CNN Money Fear and Greed index showed easing in the overall fear level, with the index moving to the "Fear" zone on Monday. U.S. stocks closed sharply higher on Monday, with the Dow Jones recording... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Earnings Scheduled For October 31, 2023
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is expected to report quarterly earnings at $1.37 per share on revenue of... 
Via Benzinga
Pfizer, AMD And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Stocks Jump... Everything Else Dumps
Once again the fact that WW3 didn't actually break-out over the weekend sent VIX lower, smashing stocks higher and havens/hedges such as oil, crude, bonds, the dollar, and bitcoin all declined. 
Via Talk Markets
Topics Bonds Stocks
Exposures Debt Markets US Equities
7 Low-Risk Stock Picks to Double Your Money
As we get closer to the new year, investors may want to consider these top, low-risk stocks to double your money. 
Via InvestorPlace
Monday's Market Minute: Fed In Focus This Week, But Plenty Of Earnings & Data As Well
While the primary focus this week will be on the Federal Reserve’s policy announcement on Wednesday, it never hurts to take a market minute to look at a few of the other focal points for investors and... 
Via Benzinga
Topics Economy
Exposures Interest Rates
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.